Sonova Holding (OTCMKTS:SONVY) Given Average Rating of "Reduce" by Brokerages

Key Points

• Sonova Holding (OTCMKTS:SONVY) has received an average consensus recommendation of “Reduce” from nine analysts, with four ratings classified as a sell, four as a hold, and one as a strong buy.
• Recent downgrades from analysts include BNP Paribas and Barclays, which have both cut their ratings on Sonova to “strong sell”.
• Sonova's current stock price is around $55.42, with a recent range between a 12-month low of $52.83 and a high of $77.56.

Sonova Holding (OTCMKTS:SONVY - Get Free Report) has been assigned a consensus recommendation of "Reduce" from the nine analysts that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a strong buy rating to the company.

A number of research firms have commented on SONVY. BNP Paribas cut shares of Sonova from a "strong-buy" rating to a "strong sell" rating in a research note on Wednesday, June 11th. Barclays cut shares of Sonova from a "hold" rating to a "strong sell" rating in a research note on Friday, June 20th. Kepler Capital Markets raised shares of Sonova from a "strong sell" rating to a "hold" rating in a research note on Friday, June 6th. Zacks Research upgraded shares of Sonova from a "strong sell" rating to a "hold" rating in a report on Thursday, August 28th. Finally, Sanford C. Bernstein upgraded shares of Sonova from a "hold" rating to a "strong-buy" rating in a report on Friday, July 18th.

Sonova Stock Performance

Shares of OTCMKTS:SONVY opened at $55.42 on Friday. The company has a 50 day moving average of $57.60 and a 200 day moving average of $59.43. Sonova has a 12 month low of $52.83 and a 12 month high of $77.56. The company has a quick ratio of 0.96, a current ratio of 1.27 and a debt-to-equity ratio of 0.45.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.